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Collagen VI (COLVI) is a non-fibrillar collagen expressed in skeletal muscle and most
connective tissues. Mutations in COLVI genes cause two major clinical forms, Bethlem
myopathy and Ullrich congenital muscular dystrophy (UCMD). In addition to congenital
muscle weakness, patients affected by COLVI myopathies show axial and proximal joint
contractures and distal joint hypermobility, which suggest the involvement of the tendon
function. We examined a peroneal tendon biopsy and tenocyte culture of a 15-year-old
patient affected by UCMD with compound heterozygous COL6A2 mutations. In
patient’s tendon biopsy, we found striking morphological alterations of tendon fibrils,
consisting in irregular profiles and reduced mean diameter. The organization of the
pericellular matrix of tenocytes, the primary site of collagen fibril assembly, was severely
affected, as determined by immunoelectron microscopy, which showed an abnormal
accumulation of COLVI and altered distribution of collagen I (COLI) and fibronectin (FBN).
In patient’s tenocyte culture, COLVI web formation and cell surface association were
severely impaired; large aggregates of COLVI, which matched with COLI labeling, were
frequently detected in the extracellular matrix. In addition, metalloproteinase MMP-2,
an extracellular matrix-regulating enzyme, was increased in the conditioned medium of
patient’s tenocytes, as determined by gelatin zymography and western blot. Altogether,
these data indicate that COLVI deficiency may influence the organization of UCMD
tendon matrix, resulting in dysfunctional fibrillogenesis. The alterations of tendon matrix
may contribute to the complex pathogenesis of COLVI related myopathies.
Keywords: Collagen VI, Ullrich congenital muscular dystrophy (UCMD), pericellular matrix, metalloproteinases,
tendon
INTRODUCTION
Tendons are composed of relatively rare cells (tendon fibroblasts) scattered within a
predominant dense connective tissue arranged in an highly ordered ECM, mainly constituted
by collagen fibrils, which are hierarchically organized to withstand tensile forces transmitted
from muscles to bone axis (Kadler et al., 1996). Fibrils contain mostly collagen I (COLI)
and other components, which contribute to fibrillogenesis, such as collagen types III,
V, VI, XII, and XIV, as well as proteoglycans and glycoproteins (Screen et al., 2015).
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Fibril assembly is crucial for tendon function. Fibril
intermediates assemble by lateral and longitudinal association
(Birk et al., 1995). The assembly of intermediates into longer,
continuous fibrils with larger diameters dramatically increases
the tensile strength of tissues such as the tendon. Tendon
fibrillogenesis is regulated by a variety of fibril surface associated
molecules, as fibronectin (FBN), decorin, biglycan and collagens
types XII and XIV (Birk et al., 1995; Young et al., 2002;
Zhang et al., 2005). These regulatory matrix molecules
are all substrates for MMP-2/MT3-MMP, which ensures
the matrix turnover required during tendon development
(Jung et al., 2009).
Collagen VI (COLVI) is a microfibrillar collagen expressed in
most tissues. In tendons and ligaments, COLVI forms a network
of beaded filaments associated both to collagen fibrils and to
the cell surface (Bruns et al., 1986; Ritty et al., 2003). The best-
characterized and widely expressed form of COLVI is the [α1,
α2, α3] heterotrimer that further assembles intracellularly into
dimers and tetramers. After secretion, tetramers undergo end-
to-end association, giving rise to the typical 100 nm-spaced
beaded microfibrils (Bruns et al., 1986), which may form,
alternatively, fibrils by parallel alignment, or web-like structures
by multiple interconnections, depending on the association with
cell receptors and ECM-binding proteins (von der Mark et al.,
1984; Bruns et al., 1986; Wiberg et al., 2002; Knupp et al.,
2006; Koudouna et al., 2014). In humans, two novel COLVI
subunits, the α5 and α6 chains, were recently identified, which
structurally resemble the α3 chain but display a more restricted
and often alternative distribution pattern (Fitzgerald et al., 2008;
Gara et al., 2008; Sabatelli et al., 2011, 2012). In tendons, the
[α1, α2, α3] heterotrimer is abundantly expressed (Thakkar
et al., 2014), whereas the α5 chain is selectively detected at the
myotendinous junction and the α6 chain is absent (Sabatelli et al.,
2012).
Mutations in the genes encoding COLVI (COL6A1, COL6A2,
and COL6A3) cause the COLVI-related myopathies, which
comprise two major clinical forms, Bethlem myopathy (BM
[MIM 158810]) and Ullrich congenital muscular dystrophy
(UCMD [MIM 254090]), and the limb girdle and the
Myosclerosis myopathy (MM) variants. UCMD is a severe
disorder characterized by congenital muscle weakness; BM
is a mild form characterized by slowly progressive axial and
proximal muscle weakness; MM is characterized by slender
muscles with firm ‘‘woody’’ consistence and restriction of
movement of many joints (Merlini and Bernardi, 2008).
COLVI myopathies are also characterized by joint hyperlaxity
and contractures. Type and distribution of contractures are
distinguishing features of COLVI disorders. The UCMD
is characterized by proximal contractures and distal laxity,
BM by distal contractures, limb-girdle phenotype by late or
no contractures, and MM by early, diffuse, and progressive
muscle contractures resulting in severe limitation of
movement of all axial, proximal, and distal joints (Merlini
and Bernardi, 2008). Patients affected by COLVI myopathies
may also display skin abnormalities, like keloids or ‘‘cigarette
article’’ scars, dry skin, striae rubrae, and keratosis pilaris
(follicular keratosis). Thus, COLVI mutations result in
disorders with combined muscle and connective tissue
involvement.
Animal models of COLVI myopathies have been developed in
mice (Bonaldo et al., 1998; Pan et al., 2013) and zebrafish (Telfer
et al., 2010; Zulian et al., 2014). Recently, a nonsense variant
in COL6A1−/− has been detected in Landseer dogs (Steffen
et al., 2015). COL6A1 mice, a COLVI null model (Bonaldo
et al., 1998), and COL6A3 deficient mice (Pan et al., 2013)
develop a mild myopathy and tendon dysfunction possibly due
to altered tendon fibrillogenesis (Izu et al., 2011; Pan et al.,
2013). COL6A1morphant zebrafish display a severe impairment
of motor function and myotendinous junction abnormalities
(Telfer et al., 2010; Zulian et al., 2014). Altogether, these data
point to an involvement of COLVI in the regulation of tendon
function.
In order to determine whether the altered tendon
fibrillogenesis reported in animal models of COLVI myopathies
is also present in humans, we studied a tendon biopsy
and tenocyte cultures of a UCMD patient with compound
heterozygous mutations in COL6A2 gene (Martoni et al., 2009).
We found changes consistent with altered fibrillogenesis, as
indicated by fibrils abnormalities, and in vitro alterations of
COLI organization and metalloproteinase MMP-2 activity.
MATERIALS AND METHODS
Tendon Biopsies
Peroneal tendon biopsies were harvested from two healthy
subjects (17 and 21) during foot surgery and during a Grice
procedure from a previously genetically characterized UCMD
patient carrying compound heterozygous mutation for a G > A
variation at position +5 of COL6A2 intron 8 and a nonsense
mutation R366X in COL6A2 exon 12 (Martoni et al., 2009).
All patients granted informed consent. Tendon fragments
were subjected to mechanical dissociation, and maintained in
Dulbecco’s Modified Eagle Medium (DMEM) containing 1%
antibiotics plus 10% Fetal Bovine Serum (FBS; Nemoto et al.,
2013); 0.25 mM L-ascorbic acid was added to the medium to
allow COLVI tetramer secretion (Engvall et al., 1986).
Immunofluorescence and Confocal
Analysis
The immunofluorescence analysis with anti-COLVI (Millipore)
on tendon cell cultures was performed as previously reported
(Sabatelli et al., 2012). Cells grown onto coverslips were
incubated with antibodies against FBN (Sigma), COLVI
(Millipore), COLI (Abcam), and with FITC or TRITC-
conjugated anti-mouse or anti-rabbit secondary antibodies
(DAKO). Cell nuclei were stained with 1 mg/ml DAPI (Sigma-
Aldrich). Samples were mounted with an anti-fading reagent
(Molecular Probes). The confocal imaging was performed with a
Nikon A1-R confocal laser scanning microscope, equipped with
a 60×, 1.4 NA objective and with 405, 488 and 561 nm laser lines
to excite DAPI (blu), FITC and TRITC fluorescence signals. Each
final confocal image, of 1024 × 1024 pixels and 4096 gray levels,
was obtained by maximum intensity projection of 10 optical
Frontiers in Aging Neuroscience | www.frontiersin.org 2 June 2016 | Volume 8 | Article 131
Sardone et al. Tendon Alterations in UCMD
FIGURE 1 | (A) Ultrastructural analysis of normal peroneal tendon showing a tenocyte with cellular processes (p, upper panel) which define extracellular matrix
compartments containing collagen fibrils. Collagen fibrils are closely associated with the cell membrane (c, lower panel). Scale bar, 1 µm. (B) Ullrich congenital
muscular dystrophy (UCMD) tenocytes display reduced and irregular cellular processes (p). A necrotic cell with hypercondensed heterochromatin (n) and vacuoles (v)
is shown (upper lane, right panel). Note the presence of abnormal microfibrillar material accumulated in the pericellular matrix (PCM) of UCMD fibroblasts. Scale
bar, 1 µm. (C) Transmission electron microscopy of cross-sectioned normal and UCMD peroneal tendon. Normal tendon displays fibrils with regular profile. In
contrast, UCMD tendon displays smaller diameter fibrils; several aberrant fibrils with irregular profile are also observed (arrows). Scale bar, 200 nm. (D) Fibril diameter
distribution in normal and UCMD tendon. The fibrils diameter distribution was shifted toward smaller diameters in UCMD tendon compared to normal tendon, with a
significant difference in mean fibril diameter (± SEM ∗p < 0.001).
sections passed through the central region of the cells (recorded
at z-step size of 300 nm). Volume view with 3D rendering was
carried out using the NIS Elements Advanced Research Software
(Nikon).
Western Blot Analysis
Cultured tendon fibroblasts were harvested by scraping. The
media were recovered after cell treatment with 0.25 mM
L-ascorbic acid for 24 h without FBS, and concentrated with
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FIGURE 2 | (A) Immunoelectron microscopy analysis of collagen VI (COLVI) on tissue sections of normal (upper row) and UCMD (lower row) peroneal tendon
sections. In normal tendon, COLVI, identified by 15 nm colloidal gold particles, is detected among collagen fibrils (c). In contrast, in UCMD tendon, COLVI appears
concentrated in the pericellular matrix of tenocytes (PCM) and scarcely associated with the collagen fibrils (c). Scale bar, 200 µm. (B) Immunoelectron microscopy of
collagen I (COLI) (left panels) and fibronectin (FBN; right panels) in normal (upper panels) and UCMD (lower panels), showing a marked reduction of COLI and FBN in
the pericellular matrix (PCM) of UCMD tenocytes compared to normal control (c, collagen fibrils). Scale bar, 200 nm. (C) Quantitative analysis of the density of
colloidal gold particles (cgp) in the pericellular matrix (PCM), and in ECM displaced from the cells (central region, CR) of the UCMD and normal control tendon labeled
with anti-COLVI, COLI and FBN antibodies. (± SEM ∗p < 0.001).
Vivaspin sample concentrators (Vivaspin 2 MWCO10000,
GE Healthcare) according to the manufacturer’s operating
procedures. Cell lysates and concentrated culture media
were resolved by standard SDS–PAGE, electroblotted
onto a nitrocellulose membrane (Sardone et al., 2014) and
incubated with antibodies against FBN (Sigma), COLI (Abcam),
tenomodulin (TNMD; Santa Cruz), actin (Santa Cruz), MMP2
(Santa Cruz), followed by incubation with anti-mouse or anti-
rabbit horseradish peroxidize (HRP)-conjugated secondary
antibodies. Chemiluminescent detection of proteins was
carried out with the ECL detection reagent Kit (GE Healthcare
Amersham, Pittsburgh, PA, USA) according to the supplier’s
instructions.
Gelatin Zymography
The activity of MMP-2 and MMP-9 in conditioned medium
was detected using gelatin zymography, which was performed
under non-reducing conditions in a 7.5% SDS-polyacrylamide
gel containing 2 mg/ml gelatin (Mini-PROTEAN II system;
Bio-Rad Laboratories Ltd, Hempstead, UK). Gels were washed
in 2.5% Triton X-100 to remove SDS and allow renaturation
of MMPs, before they were transferred to a solution containing
50 mM Tris (pH 7.5), 5 mM CaCl2, and 1 mM ZnCl2, followed
by incubation at 37◦C for 18 h. After staining with Coomassie
brilliant blue R250 (Bio-Rad Laboratories, Hercules, CA, USA),
pro-MMPs and active MMPs were observed as white lysis bands
produced by gelatin degradation.
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Electron Microscopy Study
Tendon fragments were fixed with 2.5% glutaraldehyde in
0.1 M cacodilate buffer, postfixed with 1% osmium tetroxide
in 0.1 M cacodilate buffer and embedded in Epon812 epoxy
resin following standard procedures. For post embedding
immunoelectron microscopy, tendon fragments were fixed
with 1% glutaraldehyde in phosphate buffer, embedded in
London white resin and ultrathin sections were incubated
with an anti-COLVI (Fitzgerald et al., 2008), anti-COLI
(Abcam) and anti-FBN (Sigma) as previously reported (Sabatelli
et al., 2011), and revealed with anti-rabbit 15 nm colloidal
gold conjugated antibody (Sigma). Sections were stained
with uranyl acetate and lead citrate and observed with a
Jeol JEM-1011 transmission electron microscope operated at
100 kV. For quantitative analysis of COLVI, COLI and FBN
immunogold labeling, at least 20 fields for each sample
were acquired at the same magnification, and the labeling
density was expressed as mean of the number of gold
particles/µm2 ± SD.
Statistical Analysis
Statistical analysis was performed by Student’s t-test with the
Statistical Package for the Social Sciences Software (SPSS,
Chicago, IL, USA). The results were considered statistically
significant for p values less than 0.05.
RESULTS
By ultrastructural analysis, normal peroneal tendons showed the
presence of scattered tenocytes with long cellular processes and
well-packed and oriented collagen fibrils. The tendon matrix
appeared mainly constituted by collagen fibrils of different size
and few scattered elastin-oxytalan fibers (Figure 1A). Collagen
fibrils were present in the pericellular matrix of tenocytes,
closely associated with the cell surface (Figure 1A, lower
panel).
In contrast, patient’s tenocytes showed reduced cell processes,
and occasionally, displayed features of necrotic cells, such
as hypercondensed heterochromatin and increased vacuoles
(Figure 1B). Numerous tenocytes displayed an abnormal
accumulation of microfibrillar/reticular material in the
pericellular matrix, which determined the displacement
of collagen fibrils from the cell surface (Figure 1B). In
addition, cross-sectioned collagen fibrils displayed irregular
profiles and a ragged appearance (Figure 1C). The analysis
of the fibril diameter distribution revealed a reduced size
of patient’s fibrils compared with normal tendon, with
an increased number of small fibrils (20–60 nm) and
reduced number of large fibrils (>100 nm; Figure 1D);
moreover, the mean fibril diameter was significantly reduced
(Figure 1D).
In addition, immunoelectron microscopy study showed
that the colloidal gold particles, identifying COLVI, had an
uneven distribution in the patient’s matrix tendon, with
a conspicuous accumulation in the pericellular matrix of
tenocytes and in focal areas of the tendon matrix (Figure 2A);
moreover, the association of COLVI with collagen fibrils bundles
FIGURE 3 | (A) Immunofluorescence microscopy of COLVI antibody in normal
(CTRL, left panels) and UCMD patient (UCMD, right panels) tenocyte cultures
treated with ascorbic acid for 24 h. COLVI is early secreted in normal tenocyte
culture and associates with the cell surface (arrowheads). In UCMD tenocyte
culture, COLVI is severely reduced in the matrix and form anomalous
aggregates (arrows). The association of COLVI with the cell surface is also
impaired. Nuclei were stained with DAPI (blue). Scale bar, 20 µm.
(B) Immunofluorescence microscopy of COLVI in normal (CTRL, left panel) and
UCMD (right panel) long term tenocyte cultures showing the abnormalities of
COLVI organization in patient sample compared to complex network
developed in normal culture. Nuclei were stained with DAPI (blue). Scale bar,
20 µm.
was apparently impaired compared with the intense labeling
detected in normal tendon matrix. In addition, immunoelectron
microscopy study of COLI and FBN, both COLVI-related
components of tendon matrix, showed a marked reduction in
the pericellular matrix of UCMD tendon fibroblasts (Figure 2B).
These observations were supported by the quantitative analysis
of the number of colloidal gold particles both in the PCM
and in areas of tendon matrix displaced from the cells, which
further demonstrated significant changes of COLVI, COLI and
FBN distribution in the PCM of the UCMD tendon biopsy
(Figure 2C).
To address further the impact of COLVI deficiency on
tendon matrix organization, we studied normal and UCMD
patient tendon cultures by immunofluorescence microscopy.
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FIGURE 4 | (A) Confocal microscopy of (COLVI) and FBN in normal (upper row) and UCMD patient (lower row) tenocyte cultures; 3D surface shaded reconstruction
of an enlargement of the area defined by the white box is shown on the right. In normal tendon fibroblast culture, COLVI network co-localizes at discrete site with
FBN, as visualized in merge and 3D reconstruction images. In UCMD sample, COLVI forms anomalous aggregates, which also include FBN staining (arrows). Nuclei
were stained with DAPI (blue). Scale bar, 50 µm. (B) Confocal microscopy of (COLVI) and COLI in normal (upper row) and UCMD patient (lower row) tendon fibroblast
cultures; 3D surface shaded reconstruction of an enlargement of the area defined by the white box are shown on the right. In normal tendon fibroblast culture, COLI
and COLVI form distinct interconnected networks, as indicated by the partial association visualized in 3D reconstruction. In UCMD tendon culture, COLI forms
aggregates that match with COLVI abnormal structures. 3D reconstruction of a particular of the merge image clearly shows that collage I associates with COLVI
aggregates. Nuclei were stained with DAPI (blue). Scale bar, 50 µm.
Normal and UCMD tenocyte cultures were grown to confluence
onto coverslips and treated for different times with ascorbic
acid to assess early (24 h) and late (10 days) dynamics of
COLVI extracellular assembly. Immunofluorescence microscopy
of normal tenocyte cultures showed that COLVI was mainly
associated with the cell surface in short term cultures
(Figure 3A), while, in long-term samples, it formed a complex
and well-developed network (Figure 3B). In UCMD tenocyte
culture, COLVI was markedly reduced and poorly associated to
the cell surface (Figure 3A); when analyzed in long term cultures,
COLVI displayed a spot-like pattern, with large aggregates
scattered in the extracellular matrix (Figure 3B).
Double labeling of anti-COLVI with anti-FBN revealed
moderate changes of the FBN pattern in UCMD tenocyte
culture compared to normal control; in fact, small FBN
aggregates, which co-localized with COLVI labeling, were
detected (Figure 4A). In contrast, COLI organization
was severely affected in UCMD culture, as indicated by
anomalous aggregates which matched with COLVI deposits
(Figure 4B).
Western blot analysis of cell lysates and conditioned medium
showed comparable amount of FBN in UCMD and control
tenocyte cultures, as indicated by densitometric quantification
(Figure 5A); COLI was normally expressed in cell lysate, while
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FIGURE 5 | (A) Western blot analysis of cell lysate (Cell Layer) and
conditioned medium (Medium) of normal (CTRL) and UCMD patient (UCMD)
cultured tenocytes of FBN and COLI, and of the relative densitometric
quantification; actin was used as a loading control of cell lysates. For cell
lysate quantification, protein levels were calculated as relative intensity with
respect to actin. The respective protein levels in UCMD patient cells and
media were compared to the control (showed by the dark line, set as 1) ± SD
(*p < 0.06 vs. control). (B) Gelatin zymography of conditioned medium from
normal (CTRL) and UCMD patient showing an increased gelatinolitic activity of
MMP2 in the culture medium of patient cells. (C) Western blot analysis with
anti-MMP2 antibody, recognizing both the active (63 kDa) and non-active
pro-MMP2 (72 kDa) form in normal (CTRL) and UCMD patient (UCMD)
cultured tenocytes (Cell Layer) and conditioned medium (Medium), and the
relative densitometric quantification; actin was used as a loading control of cell
lysates, while tenomodulin (TNMD), a tenocyte marker, was used to assess
the cell phenotype. For cell lysates, protein levels were calculated as relative
intensity with respect to actin. The respective protein levels in UCMD patient
cells and media were compared to the control (showed by the dark line, set
as 1). Error bars indicate SD. (*p < 0.001 vs. control).
it was moderately reduced in the patient conditioned medium
(Figure 5A). Furthermore, we investigated the expression
and activity of gelatinases MMP2 and MMP9, both involved
in tendon matrix turnover (Veidal et al., 2011). Strikingly,
gelatin zymography of conditioned medium of patient tendon
fibroblasts displayed an increased activity of MMP2, while pro-
MMP2 and MMP9 activity were similar to that detected in
the control conditioned medium (Figure 5B). Consistent with
increased MMP2 gelatinolytic activity, western blot analysis
showed an increase of the 63 kDa active form of MMP2 in the
conditioned medium of patient tenocytes, while pro-MMP2 was
unchanged (Figure 5C). The analysis of MMP2 in cell lysates
did not showed differences between UCMD and normal tendon
cultures.
DISCUSSION
Patients with mutations in COLVI genes develop both
contractures and distal laxity, possibly due to tendon/ligament
involvement. However, the molecular basis and the mechanism
leading to these alterations remain unknown. In this article, we
report for the first time the impact of COLVI deficiency on the
organization of tendon matrix of an UCMD patient, represented
by morphological alterations of tendon fibrils, and disruption
of tenocyte pericellular matrix organization associated with
increased MMP2 activity.
COLVI was markedly reduced both in tendon sections
and tenocyte culture of the UCMD patient. This alteration
is consistent with the low protein level and the derangement
of the COLVI network previously reported in skeletal muscle
(Tagliavini et al., 2014) and skin fibroblast cultures of the same
patient (Martoni et al., 2009). On the other hand, the majority
of COLVI mutations of UCMD patients affect the assembly and
secretion of COLVI (Zhang et al., 2002; Merlini and Bernardi,
2008). This may depend on the complex mechanism of COLVI
assembly, a multistep process, which involves intracellular
formation of dimers and tetramers before secretion (Bruns et al.,
1986).
The COLVI quantitative defect was associated to striking
alterations of fibrils organization, both in tissue sections and
tenocyte cultures. The immunoelectron microscopy analysis
of tendon sections showed that COLVI was abnormally
accumulated in the pericellular matrix of the patient’s tenocytes
and in focal areas of the extracellular matrix, rather than
associated to fibrils, as in normal tendon (Bruns et al., 1986).
Similarly, aberrant COLVI aggregates were detected in patient’s
tenocyte culture, indicating that the low amount of protein
secreted is not able to organize a regular matrix. It is interesting
to note that in UCMD patients, COLVI may be reduced in
the basal lamina surrounding the muscle fibers, but is still
present/accumulated in the endomysium and perivascular space
(Pan et al., 2003). Aggregates of COLVI have also been reported
in the skin (Sabatelli et al., 2011) and in fibroblast cultures of
UCMD patients (Hicks et al., 2008; Martoni et al., 2013). It
has been proposed that mutant COLVI is not degraded but
is aberrantly accumulated in the interstitial space. As possible
consequence, COLVI non-functional deposits may hinder the
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arrangement of extracellular binding partners. Consistent with
this hypothesis, the expression of FBN and COLI was severely
affected in areas of COLVI accumulation, and in particular
in the pericellular matrix of tenocytes, as demonstrated by
immunoelectron microscopy on patient’s tendon.
The effect of aberrant COLVI expression on early assembly
of COLI and FBN, was better characterized by studying two-
dimensional tenocyte cultures. We found that COLI, and to a
lesser extent, the FBN organization were affected in patient’s
tenocyte cultures. Remarkably, COLI failed to organize a
filamentous network aligned to the cell axis, compared to the
well-oriented fibrils assembled by normal tenocytes. These data
may suggest that collage VI is involved in directional deposition
of COLI. It is interesting to note that COLVI in normal cultured
tenocytes is associated to the cell surface, and that this pattern
was impaired in patient’s culture, pointing to a role of COLVI
in cell-surface associated mechanisms, as early steps of collagen
fibril assembly (Zhang et al., 2005). The alteration of the FBN
pattern in cultured tenocytes is consistent with our previous
reports that COLVI deficiency affects the three-dimensional
organization of FBN in fibroblast cultures of UCMDand Bethlem
myopathy patients (Martoni et al., 2009), and in Col6A1-/- null
mice (Sabatelli et al., 2001).
The ultrastructural analysis of UCMD tendon showed
alterations of fibril morphology and a significant reduction of
the number of large fibrils. These data correlated with fibril
abnormalities reported in skin of UCMD patients (Kirschner
et al., 2005), and in tendons of COLVI myopathy mouse models
(Izu et al., 2011; Pan et al., 2013, 2014), and further support the
hypothesis of dysfunctional fibrillogenesis.
COLVI interacts with a large number of regulatory molecules,
including metalloproteinase MMP-2 (Freise et al., 2009).
Interestingly, we found a specific increase ofMMP-2 gelatinolytic
activity, consistent with the increase of active MMP-2 in the
medium of UCMD cultured tenocytes. It is interesting to
note that COLVI, and in particular the α2 chain, modulates the
activity ofMMP-2 by sequestering pro-MMPs in the extracellular
matrix, and blocking proteolytic activity (Freise et al., 2009).
A moderate increase of MMP-2 activity has been observed in
Col6A1-/- mice, a COLVI null model (Izu et al., 2011). MMP-2
is involved in the initiation and progression of fibril growth
and matrix assembly during tendon development (Jung et al.,
2009); increased level of MMP2 has been also reported during
tendon healing (Choi et al., 2002). We hypothesize that MMP-2
increased activity may reflect an accelerated tendon matrix
turnover in response to defects of COLVI.
Altogether, our data indicate that COLVI deficiency affects
both in vivo and in vitro the organization of matrix tendon,
resulting in dysfunctional fibrillogenesis. Fibril alterations have
been reported in some forms of Ehlers Danlos Syndrome
(EDS) with hypermobile phenotype (Kobayasi, 2004) and in an
animal model of EDS with joint phenotype (Sun et al., 2015),
suggesting common pathophysiological pathways in this group
of connective tissue disorders.
Fibril abnormalities are also regarded as a consequence
of decreased loading (Heinemeier and Kjaer, 2011), disuse,
and aging sarcopenia (Narici and Maganaris, 2007). Our data,
however, point toward a primary tendon dysfunction. In fact,
we have shown that alterations of the extracellular matrix were
also present in the patient’s cultures, effectively reducing the
importance of muscle dysfunction as a determinant of the tendon
phenotype.
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